Gyre Therapeutics, Inc.
GYRE- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001124105
No open-market purchases or sales by Gyre Therapeutics, Inc. insiders were filed in the last 90 days; 59 institutions reported holding it in 13F filings for Q2 2026, worth $57.1M in total; no superinvestor holds it.
Q3 2024 vs. Q2 2024
How the institutions holding Gyre Therapeutics, Inc. changed between Q2 2024 and Q3 2024.
All holders in Q3 2024All holders in Q2 2024
| Measure | Q2 2024 | Of which not filed for Q3 2024 | Q3 2024 | Change |
|---|---|---|---|---|
| Holders | 30 | 1 | 37 | +8 |
| Shares | 1.26M | 499.5K | 1.61M | +852.0K (+112.4%) |
| Value | $15.0M | $5.96M | $20.2M | +$11.1M (+123.2%) |
1 institution that held it in Q2 2024 haven't filed for Q3 2024 yet. Not filing isn't selling, so the changes leave them out.
New holders (12)
Institutions that held Gyre Therapeutics, Inc. at the end of Q3 2024 but not at the end of Q2 2024.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| BlackRock, Inc. | 514,421 | $6.45M | 0.00% |
| Advantage Alpha Capital Partners LP | 26,634 | $334.0K | 0.08% |
| Goldman Sachs Group Inc | 18,799 | $235.7K | 0.00% |
| Mirae Asset Global ETFs Holdings Ltd. | 3,861 | $48.4K | 0.00% |
| FMR LLC | 3,742 | $46.9K | 0.00% |
| Belvedere Trading LLC | 2,515 | $31.5K | 0.00% |
| Nisa Investment Advisors, LLC | 84 | $1.05K | 0.00% |
| Sterling Capital Management LLC | 21 | $263 | 0.00% |
| Capital Performance Advisors LLP | 6 | $75 | 0.00% |
| Danske Bank A/S | 1 | $13 | 0.00% |
| CWM, LLC | 30 | $0 | 0.00% |
| Covestor Ltd | 6 | $0 | 0.00% |
Sold out (4)
Institutions that held Gyre Therapeutics, Inc. at the end of Q2 2024 and filed for Q3 2024 without it.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| Winton Group Ltd | 18,467 | $220.3K |
| Renaissance Technologies LLC | 13,900 | $165.8K |
| Marshall Wace, LLP | 10,720 | $127.9K |
| Acadian Asset Management LLC | 1 | $0 |
Not filed for Q3 2024 yet (1)
Institutions that held Gyre Therapeutics, Inc. at the end of Q2 2024 and haven't filed a 13F for Q3 2024. Not filing isn't selling, so they aren't counted as sold out.
| Institution | Shares, Q2 2024 | Value, Q2 2024 |
|---|---|---|
| BlackRock Inc. | 499,489 | $5.96M |